Latest Lead News

St George Mining has restructured its Lithium Star joint venture, with battery giant Amperex Technology Limited exchanging its 10% JV stake for a 12.5 million shareholding in St George at a 36% premium. This move consolidates lithium exploration under St George while giving ATL exposure to the Araxá niobium-rare earths project and offtake rights on future lithium production.

4DMedical launches the CLEAR clinical evidence program to accelerate adoption of its CT:VQ™ imaging technology in the US acute pulmonary embolism market, aiming to expand its addressable market to US$3 billion.

Megado Minerals is poised to kick off its maiden drilling campaign at the Iberian Copper Project in northern Spain, targeting historic copper oxide deposits and exploring for deeper sulphide mineralisation with new geophysical surveys underway.

Nelson Resources has appointed Nevada Rand LLC to lead the next phase of underground diamond drilling at its Gold Point Project in Nevada, targeting high-grade vein extensions beyond historic workings.

Black Bear Minerals has engaged Ausenco for detailed restart studies at its Shafter Silver Project, while securing a non-binding financing support letter from Export Finance Australia to explore funding pathways aligned with U.S.-Australia critical minerals priorities.

Kelsian’s Transit Systems West has locked in a two-year extension for Sydney’s Region 6 bus services, adding $500 million in revenue and advancing its electric bus fleet rollout.

AoFrio Limited has initiated a 1-for-7 renounceable rights offer at NZ$0.07 per share aiming to raise nearly NZ$5 million. This follows a recent $4.56 million placement and supports an aggressive growth strategy targeting $300 million revenue by 2030.

Intelligent Monitoring Group (ASX:IMB) has finalized its A$37 million purchase of Wormald NZ and Red Wolf, expanding its New Zealand footprint and projecting a 20.9% accretion in earnings per share.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Bounty Oil & Gas NL has locked in A$4.5 million from a heavily oversubscribed share placement, with proceeds earmarked for drilling, facility upgrades, and exploration across its Australian assets.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.